Magnetar Financial LLC Purchases 17,287 Shares of Cigna Group $CI

Magnetar Financial LLC increased its position in Cigna Group (NYSE:CIFree Report) by 789.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 19,478 shares of the health services provider’s stock after purchasing an additional 17,287 shares during the period. Magnetar Financial LLC’s holdings in Cigna Group were worth $5,615,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Mirae Asset Global Investments Co. Ltd. grew its stake in shares of Cigna Group by 11.7% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 45,235 shares of the health services provider’s stock worth $13,039,000 after buying an additional 4,738 shares during the last quarter. Maj Invest Holding A S raised its stake in Cigna Group by 2.4% during the third quarter. Maj Invest Holding A S now owns 422,728 shares of the health services provider’s stock valued at $121,854,000 after buying an additional 10,042 shares during the last quarter. Providence Capital Advisors LLC boosted its holdings in Cigna Group by 1,016.8% in the third quarter. Providence Capital Advisors LLC now owns 8,510 shares of the health services provider’s stock worth $2,453,000 after acquiring an additional 7,748 shares in the last quarter. National Pension Service grew its stake in shares of Cigna Group by 3.2% in the third quarter. National Pension Service now owns 683,751 shares of the health services provider’s stock worth $197,091,000 after acquiring an additional 21,203 shares during the last quarter. Finally, SCS Capital Management LLC grew its stake in shares of Cigna Group by 39.1% in the second quarter. SCS Capital Management LLC now owns 30,633 shares of the health services provider’s stock worth $10,127,000 after acquiring an additional 8,609 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Trading Down 0.6%

Shares of NYSE:CI opened at $260.79 on Thursday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.74. Cigna Group has a 1 year low of $239.51 and a 1 year high of $350.00. The company has a market cap of $68.73 billion, a P/E ratio of 11.76, a PEG ratio of 0.91 and a beta of 0.27. The stock’s fifty day moving average price is $280.01 and its 200-day moving average price is $283.29.

Cigna Group (NYSE:CIGet Free Report) last released its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, topping the consensus estimate of $7.88 by $0.20. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The company had revenue of $72.50 billion during the quarter, compared to the consensus estimate of $69.53 billion. During the same period last year, the company earned $6.64 EPS. Cigna Group’s revenue for the quarter was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Sell-side analysts expect that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th will be issued a dividend of $1.56 per share. The ex-dividend date of this dividend is Thursday, March 5th. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 annualized dividend and a dividend yield of 2.4%. Cigna Group’s dividend payout ratio is presently 28.13%.

Insider Activity at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the sale, the insider owned 32,647 shares of the company’s stock, valued at approximately $9,432,044.77. The trade was a 6.60% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the sale, the insider owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. This represents a 23.26% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.70% of the stock is owned by insiders.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the company. TD Cowen lifted their price target on Cigna Group from $333.00 to $338.00 and gave the stock a “buy” rating in a research report on Monday, February 9th. Piper Sandler cut their price objective on shares of Cigna Group from $374.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, March 3rd. Barclays decreased their target price on shares of Cigna Group from $305.00 to $303.00 and set an “overweight” rating for the company in a report on Friday, February 6th. Sanford C. Bernstein reiterated a “market perform” rating on shares of Cigna Group in a research note on Wednesday, March 4th. Finally, Jefferies Financial Group increased their price target on shares of Cigna Group from $310.00 to $333.00 and gave the company a “buy” rating in a report on Monday, February 9th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, Cigna Group presently has a consensus rating of “Moderate Buy” and an average price target of $330.42.

Get Our Latest Research Report on CI

Cigna Group Company Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Read More

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.